Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study
Author:
Publisher
Elsevier BV
Subject
Ophthalmology
Reference12 articles.
1. Morphometric analysis of angiograms of exudative lesions in age-related macular degeneration;Ali;Arch Ophthalmol,2004
2. Neovascular age-related macular degeneration: natural history and treatment outcomes;Pauleikhoff;Retina,2005
3. Clinicopathological correlation in exudative age related macular degeneration: histological differentiation between classic and occult choroidal neovascularisation;Lafaut;Br J Ophthalmol,2000
4. Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes—TAP report no. 3;Arch Ophthalmol,2002
5. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials—TAP report 2;Arch Ophthalmol,2001
Cited by 1120 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Chrysin alleviates DNA damage to improve disturbed immune homeostasis and pro-angiogenic environment in laser-induced choroidal neovascularization;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2024-03
2. Long term follow up of patients with MNV3 treated with intra-vitreal Aflibercept;European Journal of Ophthalmology;2024-02-02
3. AGE-RELATED MACULAR DEGENERATION INJECTION FREQUENCY;Retina;2024-02
4. The Effect of a Loading Dose Regimen in the Switch to Brolucizumab for Patients with Aflibercept-Resistant nAMD;Journal of Ophthalmology;2024-01-30
5. Short-term response to anti-VEGF as indicator of visual prognosis in refractory age-related macular degeneration;Eye;2024-01-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3